HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence.

Abstract
The aim of this study was to assess the effectiveness and safety of intracavernous injections of a four-drug vasoactive mixture in diabetic patients with organic impotence. A group of 60 diabetic patients with either pure neurogenic, pure vasculogenic or mixed neurovasculogenic impotence were treated with intracavernous injections of a combination of 12.1 mg/ml papaverine hydrochloride, 1.01 mg/ml phentolamine mesylate, 10.1 micrograms/ml prostaglandin E1 and 0.15 mg/ml atropine sulphate ('full-dose' mixture). A mixture of the same drugs but at one-third concentrations ('reduced-dose' mixture) was also used. The mean (+/- SEM) volumes of the full-dose and reduced-dose mixtures used were 0.21 +/- 0.03 ml and 0.31 +/- 0.02 ml, respectively. All the patients were able to sustain a rigid erection at the end of the titration phase of the study. At a mean follow-up of 18 months, 48 patients (80%) were successfully using the mixture, 6 patients (10%) were using the mixture at a dose lower than the initial dose and 6 patients (10%) had dropped out from the injection therapy. No major complications were seen. The association of multiple vasoactive drugs which use different mechanisms of action, thus exerting a pharmacological synergism, is an effective and safe procedure in intracavernous pharmacotherapy for diabetic patients with organic impotence.
AuthorsF Montorsi, G Guazzoni, F Bergamaschi, M Zucconi, P Rigatti, G Pizzini, A Miani, G Pozza
JournalActa diabetologica (Acta Diabetol) Vol. 31 Issue 1 Pg. 1-5 (Apr 1994) ISSN: 0940-5429 [Print] Germany
PMID8043890 (Publication Type: Journal Article)
Chemical References
  • Drug Combinations
  • Atropine
  • Papaverine
  • Alprostadil
  • Phentolamine
Topics
  • Adult
  • Aged
  • Alprostadil (administration & dosage, therapeutic use)
  • Atropine (administration & dosage, therapeutic use)
  • Diabetes Complications
  • Drug Combinations
  • Erectile Dysfunction (drug therapy, etiology, physiopathology)
  • Follow-Up Studies
  • Humans
  • Injections
  • Male
  • Middle Aged
  • Papaverine (administration & dosage, therapeutic use)
  • Penile Erection (drug effects)
  • Phentolamine (administration & dosage, therapeutic use)
  • Self Administration
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: